v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Product Information [Line Items]      
Net loss $ 12,741,962 $ 5,471,649  
Net cash used in operations 5,389,695 4,780,930  
Accumulated deficit 62,807,817 49,825,855  
Stockholders' deficit 6,801,055 4,945,362 $ 307,595
Working capital deficit 2,808,736    
Contract liabilities, revenue recognized 303,648    
Uncompleted contract liabilities, revenue recognized $ 54,600    
Research and development transaction term The transaction term is for 5-years, starting in January 2022    
Cash FDIC insured amount $ 186,466 68,122  
Revenue 567,905 505,604  
Accounts receivable 32,125  
Deferred revenue 156,550 135,150  
Patient reporting and contract research expense 272,904 860,954  
Uncertain tax positions 0 0  
Income tax, interest and penalties $ 0 $ 0  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]      
Product Information [Line Items]      
Concentration risk, percentage 21.00% 31.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]      
Product Information [Line Items]      
Concentration risk, percentage 15.00% 12.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]      
Product Information [Line Items]      
Concentration risk, percentage 14.00% 12.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Four [Member]      
Product Information [Line Items]      
Concentration risk, percentage 10.00% 11.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]      
Product Information [Line Items]      
Concentration risk, percentage 59.00%    
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]      
Product Information [Line Items]      
Concentration risk, percentage 41.00%    
Customer Concentration Risk [Member] | Deferred Revenue [Member] | Customer One [Member]      
Product Information [Line Items]      
Concentration risk, percentage 65.00% 56.00%  
Customer Concentration Risk [Member] | Deferred Revenue [Member] | Customer Two [Member]      
Product Information [Line Items]      
Concentration risk, percentage 24.00% 24.00%  
Customer Concentration Risk [Member] | Deferred Revenue [Member] | Customer Three [Member]      
Product Information [Line Items]      
Concentration risk, percentage   16.00%  
General and Administrative Expense [Member]      
Product Information [Line Items]      
Research and development expense $ 150,000 $ 0  
Minimum [Member]      
Product Information [Line Items]      
Property and equipment, estimated useful lives 3 years    
Maximum [Member]      
Product Information [Line Items]      
Property and equipment, estimated useful lives 5 years    
Cash FDIC insured amount $ 250,000